The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with CDK 4/6 inhibitor use for patients with advanced, hormone positive, HER-2-negative breast cancer.
 
Christine B. Weldon
Consulting or Advisory Role - Genentech (Inst)
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Lilly (Inst); National Comprehensive Cancer Network (Inst); Pfizer (Inst); The Merck Foundation (Inst)
Travel, Accommodations, Expenses - Genentech (Inst)
 
Julia R. Trosman
Consulting or Advisory Role - Genentech (Inst)
Research Funding - Genentech (Inst); National Comprehensive Cancer Network (Inst); Pfizer (Inst); The Merck Foundation (Inst)
 
Xi Li
No Relationships to Disclose
 
William John Gradishar
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Genentech/Roche; merck; Pfizer; Puma Biotechnology; Seagen